SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

13 May 2024 Evaluate
The revenue zoomed 12.39% to Rs. 1173.87 millions for the quarter ended March 2024 as compared to Rs. 1044.49 millions during the corresponding quarter last year.Profit saw a slight increase of 10.50%to Rs. 78.90  millions from Rs. 71.40 millions.Operating Profit saw a handsome growth to 169.55 millions from 157.50 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1173.87 1044.49 12.39 3654.73 3965.31 -7.83 3654.73 3965.31 -7.83
Other Income 15.31 6.98 119.34 46.91 64.31 -27.06 46.91 64.31 -27.06
PBIDT 169.55 157.50 7.65 447.94 576.21 -22.26 447.94 576.21 -22.26
Interest 22.77 12.70 79.29 69.24 55.75 24.20 69.24 55.75 24.20
PBDT 146.78 144.80 1.37 378.70 520.46 -27.24 378.70 520.46 -27.24
Depreciation 38.75 45.78 -15.36 148.29 161.28 -8.05 148.29 161.28 -8.05
PBT 108.03 99.02 9.10 230.41 359.18 -35.85 230.41 359.18 -35.85
TAX 29.13 27.62 5.47 62.84 109.09 -42.40 62.84 109.09 -42.40
Deferred Tax 42.01 11.43 267.54 54.55 46.30 17.82 54.55 46.30 17.82
PAT 78.90 71.40 10.50 167.57 250.09 -33.00 167.57 250.09 -33.00
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 487.26 0.00
PBIDTM(%) 14.44 15.08 -4.21 12.26 14.53 -15.66 12.26 14.53 -15.66

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×